LGALS3 and glycogen storage disease VI: Indeed, higher serum levels of galectin-3 in individuals with IBD have been reported, yet these upregulated amounts of systemic galectin-3 did not effectively differentiate between active disease and remission in patients with UC and CD [145,146] (Table 1).